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Quantitative Analysis of the Contribution
of TCR/pepMHC Affinity
and CD8 to T Cell Activation
examined or by the particular MHC product that served
as the class I ligand.
Although CD8 contributes to recognition of class I
products, the TCR determines the peptide specificity of
the CTL. Various studies have shown that the affinities




of productive TCR:pepMHC interactions are low, with
KD values in the 1 to 50 M range (Davis et al., 1998;Summary
Gascoigne et al., 2001). There has been some disagree-
ment on whether it is the affinity (i.e., equilibrium bindingThe relative roles of CD8, TCR:pepMHC affinity, and
constant) or the dissociation rate of the TCR:pepMHCTCR:pepMHC dissociation rate in T cell activation have
interaction that is more important in determining T cellremained controversial. To determine the relation-
activity. The kinetic proofreading (McKeithan, 1995) andships among these factors, we used T cells transfected
serial triggering (Valitutti et al., 1995) models are predi-with normal and in vitro engineered  TCRs, in the
cated on the importance of dissociation rate (or lifetimepresence or absence of CD8. The TCRs exhibited a
of association). The serial triggering model requires mul-wide range of affinities (KD values of 80 M to 5 nM).
tiple TCRs to be engaged by a single pepMHC complex,T cells with the highest affinity TCRs were efficiently
and thus it predicts that long TCR:pepMHC lifetimesstimulated by peptide, with or without CD8. In contrast,
would prevent serial TCR triggering and thus limit T cellCD8 was required for T cells that expressed TCRs
activity. This hypothesis received some support from awith affinities typical of syngeneic reactions (KD values
study with TCRs specific for pVSV/Kb in which an appar-above 3 M). The results suggest that virtually all
ent increase in dissociation lifetime yielded a less activenormal syngeneic interactions require CD8, which en-
CD8-positive T cell transfectant (Kalergis et al., 2001).hances peptide sensitivity by one million-fold or more.
In contrast, our recent work using TCRs with high affinity
in CD8-negative transfectants did not reveal such anIntroduction
effect (Holler et al., 2001). Since our study was per-
formed in the absence of CD8, it remained possible thatThe specific recognition of peptides bound to class I
inhibitory effects of high-affinity TCRs would only beproducts of the MHC is dictated by the  T cell receptor
manifested in the presence of CD8.expressed by cytotoxic T lymphocytes (CTLs). It has
The present study examined the effects of CD8,been known for some time that the accessory molecule
CD8, and TCR affinity using the same T cell hybridomaCD8 facilitates the activity of CTLs (Gao and Jakobsen,
transfection system, thereby eliminating possible differ-2000; Parnes, 1989), but only recently has it become
ences in membrane effects (Fahmy et al., 2001) or theclear that it can do so both by its cooperative effects
state of differentiation and thus CD8 glycosylation (Dan-on TCR:pepMHC binding (Daniels and Jameson, 2000;
iels et al., 2001; Moody et al., 2001a). Our system in-Xu et al., 2001) and by enhanced signaling (reviewed in
volves the TCR from mouse CTL clone 2C that recog-Gao et al., 2002). Signaling is enhanced by recruitment
nizes the alloantigen Ld and the syngeneic MHC Kb. Theof the CD8-associated cytoplasmic kinase p56Lck to the
possible role of CD8 in the function of 2C T cells hasTCR-associated CD3 complex (Xu and Littman, 1993).
itself been the topic of a number of studies (Al-RamadiThe CD8 molecule is expressed predominantly as an
et al., 1995; Cai et al., 1997; Cai and Sprent, 1994, 1996;
 heterodimer on mature CTLs, but it can also exist
Cho et al., 2001; Daniels and Jameson, 2000). These
as an homodimer. There have been conflicting results
studies have shown that activation by the strong alloge-
regarding the relative effects of CD8 compared to
neic agonist QL9/Ld is less CD8 dependent than activa-
CD8 on the contribution to class I MHC binding. In tion by the strong syngeneic agonist SIYR/Kb. The differ-
some cases, CD8 has been shown to predominate in ence in CD8 dependence appears to be due to the higher
binding to class I MHC (Devine et al., 1999), whereas affinity of the 2C TCR for QL9/Ld (KD 1 M) comparedother studies have shown that CD8 is more important to SIYR/Kb (KD 30 M) (Cho et al., 2001).in binding (Bosselut et al., 2000; Renard et al., 1996). In In order to quantitate the relationship between TCR
vitro studies with purified CD8 and class I MHC suggest affinities and CD8 requirement, and to further examine
that the affinities of CD8 and CD8 for class I MHC the notion of an optimum window of TCR lifetimes, we
are similar (KD 100 M), although more recent results have used a panel of 2C TCR mutants engineered in
suggest their affinities for different MHC class I products vitro for higher affinities. These TCR mutants were trans-
may vary (Moody et al., 2001b). Two studies have shown fected with or without the CD8 gene or CD8/CD8
that the glycosylation of CD8 differs between immature genes into the  T cell hybridoma 58/. T cells with
thymocytes and mature CTLs and that the extent of the highest affinity TCRs (KD  5 to 3000 nM, t1/2  30
glycosylation affects the binding of the class I MHC to 1500 s) were efficiently stimulated by peptide at 10-
product (Daniels et al., 2001; Moody et al., 2001a). These to 1000-fold lower concentrations than T cells with lower
findings suggest that previous studies might have been affinity TCRs, and they were stimulated in the presence
confounded by the differences in the T cells that were or absence of CD8. The effects of CD8 on T cells with
lower affinity TCRs (KD values above 3 M) were dra-
matic, as peptide sensitivity could be increased as much*Correspondence: d-kranz@uiuc.edu
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Table 1. Summary of Binding Data for 2C TCR and TCR Mutants
TCR pMHC kon (103)a fold  koff (102)a fold  t1/2 (s) KD (nM) fold  Methodb
2Cc p2Ca/Ld 8.3 - 2.7 - 25.7 3,300 - SPR-Kin
2Cd p2Ca/Ld 210 - 2.6 - 27 120 - SPR-Kin
2Ce p2Ca/Ld - - - - - 1,500 - Fab comp-Keq
2Cc QL9/Ld 6.3 - 2.5 - 27.7 3,900 - SPR-Kin
2Ce QL9/Ld - - - - - 750 - Fab comp-Keq
2Cf QL9/Ld - - - - - 1,900 - SPR-Kin, Keq
m6 p2Ca/Ld 99 12 0.12 23 578 12 274 Flow noff3, neq4
m6 QL9/Ld 155 25 0.08 31 815 5.5 713 Flow noff3, neq5
m6 Y5/Ld 115 - 0.06 - 1175 5.1 - Flow noff2, neq3
m6 M5/Ld 147 - 0.50 - 139 34.1 - Flow noff2, neq3
m6 H5/Ld - - - - - 77.8 - Flow neq4
m6 Q5/Ld - - - - - 166.5 - Flow neq2
m13 p2Ca/Ld - - 0.12 23 596 - - Flow noff3
m13 QL9/Ld 130 21 0.13 19 531 10 390 Flow noff4, neq2
m13 Y5/Ld 93 - 0.05 - 1556 5.4 - Flow noff2, neq2
2Cc dEV8/Kb 2.2 - 18.5 - 3.7 84,100 - SPR-Kin
m33 dEV8/Kb - - - - - 38,000 2.2 ELISA
m67 dEV8/Kb 86 39 56.7 0.33 1.2 6,570 18 SPR-Kin
2Cc SIYR/Kb 2.3 - 7.5 - 9.2 31,900 - SPR-Kin
m33 SIYR/Kb 233 101 0.66 11 105 28.3 1125 Flow noff2, neq3
m67 SIYR/Kb 277 118 0.44 17 158 15.9 2010 Flow noff3, neq3
a kon (s1M1103); koff (s1102)
b Measurements were performed by the method indicated: SPR-Kin, kinetic data using surface plasmon resonance; SPR-Keq, equilibrium
binding data using surface plasmon resonance; Fab comp-Keq, soluble labeled Fab fragments inhibited with either soluble pMHC or soluble
TCR; Flow noff, dissociation rates of soluble TCR bound to surface-pMHC on T2 cells, measured by flow cytometry; Flow neq equilibrium binding
of soluble TCR to surface-pMHC on T2 cells, measured by flow cytometry; ELISA, enzyme-linked immunoassay using soluble TCRs to inhibit
binding of pMHC to anti-MHC on well. See Experimental Procedures and Holler et al. (2002) for further description of assays.
c Data for 2C wt TCR interactions from Garcia et al. (1997); fold change () for mutants are relative to these values.
d Data for 2C wt TCR interaction with p2Ca/Ld from Corr et al. (1994).
e Data for 2C wt TCR interactions from Schodin et al. (1996a) and Schlueter et al. (1996).
f Data for 2C single-chain TCR/QL9-Ld interaction from Manning et al. (1999).
as seven orders of magnitude by transfection with CD8 ences in Ld binding stability (Schlueter et al., 1996;
Schodin et al., 1996b).and nine orders of magnitude by cotransfection with
CD8 and CD8. Even under the most optimal condi-
tions (high-affinity TCR and CD8), there appears to T Cell Hybridomas Transfected with TCRs and CD8
The -negative T cell hybridoma 58/ was cotrans-be a peptide sensitivity threshold (SD50 1 pM) that is
probably determined by the minimal number of TCR:li- fected with the 2C wt  chain gene and one of five
different  chain genes from 2C and the mutants m6,gand complexes necessary to signal a T cell.
m13, m33, and m67. Stable transfectants that ex-
pressed similar levels of TCR were identified based onResults
their staining with anti-V antibody KJ16 (Figure 1). Mul-
tiple independent lines were analyzed for several of theBinding Properties of TCRs
The panel of 2C TCR mutants used in this study has TCRs and although the amount of IL-2 released upon
peptide stimulation was variable, the sensitization dosesbeen described previously (Holler et al., 2001, 2002).
The TCR mutants were isolated by yeast display of a (SD50  amount of peptide that yielded 50% maximal
stimulation) were very similar (data not shown).2C scTCR library mutated in five residues of the CDR3
region (Holler et al., 2000). The TCRs were specific for The gene for CD8 was cotransfected into the TCR
lines (neomycin resistant) with an hygromycin-selectablethe allogeneic ligand QL9/Ld or the syngeneic ligands
SIYR/Kb and dEV8/Kb. None of the TCRs bound de- plasmid. Individual clones were examined by flow cy-
tometry with antibody 53-6.7 and clones with similartectably to the null pepMHC complexes MCMV/Ld or
OVA/Kb. Table 1 summarizes the KD values and lifetimes levels of CD8 were identified (Figure 1). Similarly,
clones that expressed both CD8 and CD8 were pro-of dissociation of the TCRs with higher affinity for QL9/
Ld (m6, m13) or SIYR/Kb and dEV8/Kb (m33, m67). KD duced by cotransfection of CD8 and a puromycin-
selectable plasmid into TCRCD8 cell lines. Individualmeasurements ranged from 80 M for the wt 2C:dEV8/
Kb interaction to 5 nM for the m6:QL9/Ld interaction. clones were examined by flow cytometry with antibody
53-5.8 for CD8 and antibody 53-6.7 for CD8 andDissociation lifetimes (t1/2 values) ranged from 1 to
1500 s. We also examined the affinities or lifetimes for clones that expressed CD8 were identified (Figure 1).
As the levels of CD8 may have been higher than thethe binding of m6 to various QL9 variant peptides (at
position 5, wt Phe) or the eight residue variant p2Ca. levels of CD8, only qualitative conclusions about the
effects of these two subunits could be made from thisThese variants represent a collection of ligands with
diverse affinities for the 2C TCR and with known differ- panel of transfectants. All of the clones were shown to
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Figure 1. Flow Cytometric Analysis of TCR,
CD8, and CD8 Surface Levels on T Cell
Hybridoma Transfectants
The TCR -negative T cell hybridoma 58/
was transfected with the wild-type 2C  chain
gene, together with either wild-type 2C 
chain gene or the indicated mutant  chain
genes (m6, m13, m33, or m67). Stable
TCR transfectants were further transfected
with the CD8 gene (). TCR/CD8 transfec-
tants were further transfected with the CD8
gene (). (A) TCR surface levels were moni-
tored with biotinylated anti-V8 antibody
KJ16, followed by strepavidin-phycoerythrin.
(B) CD8 and CD8 levels were monitored
with the CD8-specific antibodies 53-6.7 and
53-5.8, respectively.
release IL-2 in the presence of the specific peptides, the 2C and m6 transfectants provided a diverse group
of agonists to explore the effects of TCR affinity andbut not null peptides.
CD8 within a single class I system.
Peptide titrations were performed with 2C and m6Activity of T Cell Hybridomas Transfected
with TCRs and CD8 transfectants (Figure S1 at http://www.immunity.com/
cgi/content/full/11/2/255/DC1). In order to compare theEach of the CD8-negative, CD8, or CD8 transfec-
tants was incubated with T2-Ld or T2-Kb cells in the results more easily, average SD50 values for each peptide
were calculated from multiple titrations and plotted forpresence of various concentrations of the cognate pep-
tides, p2Ca and QL9, or SIYR and dEV8 (Figure 2). Re- the CD8-negative transfectants (Figure 3A). It was ap-
parent that only the highest affinity QL9 variants (M5,sults with the transfectants that expressed wt 2C TCR
were consistent with previous studies that used CTL Y5, H5) were able to stimulate 2C in the absence of CD8.
In contrast, m6 T cells were stimulated 10- to 1000-clone 2C or T cells from 2C TCR transgenic mice (Cai
and Sprent, 1994, 1996; Cho et al., 2001; Daniels and fold more effectively by these peptides, and they recog-
nized the Q5, N5, and E5 variants in the absence of CD8.Jameson, 2000). Accordingly, p2Ca/Ld and QL9/Ld were
both capable of activating 2C TCR transfectants in the Nevertheless, R5, K5, and D5 did not stimulate m6
transfectants, consistent with the lower affinity pre-absence of CD8, whereas activation by SIYR/Kb required
CD8. In contrast, dEV8/Kb did not stimulate 2C TCR dicted for 2C TCR with these peptide-Ld complexes
(Schodin et al., 1996b).transfected cells even with CD8 (Figure 2). In our
experience, dEV8/Kb does not act as a weak agonist for CD8 transfectants of the 2C (Figure 3B) and m6
(Figure 3C) TCRs were capable of recognizing Ld associ-2C transgenic T cells, although it is a very weak agonist
for CTL clone 2C (P. Lee and D.M.K., unpublished data). ated with the lowest affinity QL9 variants. For example,
the CD8 2C transfectant now recognized all peptidesEach of the mutant TCR transfectants was stimulated
very efficiently by the cognate pepMHC ligands (Figure except D5, with sensitivities in the micromolar range.
The CD8 m6 transfectant recognized all peptides2). There was not an optimum window of affinity or disso-
ciation rate above which T cell activity was diminished. including D5, with sensitivities in the nanomolar range.
The relatively higher activity associated with R5 and K5This finding applied to T cells that did or did not express
CD8 subunits and to T cells that recognized the Ld or appears to be a consequence of their greater stability
in complex with Ld (see below). Results with R5 andKb class I ligands. The quantitative relationships among
peptide activity (sensitization dose), pepMHC stability, recognition by the CD8 m6 transfectant most dra-
matically illustrate the potential contribution of CD8,TCR affinity, and CD8 requirements are described
below. as this peptide had a 107 increase in activity (from 	 1
mM to 100 pM) due to CD8.
The significant enhancement in recognition of theRole of CD8 in Recognition and Activity of Peptide
peptides could be improved by one to two orders ofQL9 Variants and Allogeneic Ld
magnitude by the introduction of CD8 into transfec-We have shown previously that QL9 variants at position
tants (Figures 3B and 3C). This enhancement was most5 (Phe) exhibit a spectrum of activities with 2C T cells,
notable for the m6 transfectants that showed an aver-and that this residue affects both the stability of Ld com-
age increase in sensitivity of 15-fold. The net result ofplex and the binding affinity of the TCR (Schlueter et
CD8 expression was apparent in the sensitivity ofal., 1996). A model of QL9/Ld suggested that the side
these 2C TCR transfectants, which ranged from approxi-chain of Phe5 points toward the 1 helix (Speir et al.,
mately 1 M to 100 pM (excluding D5). Perhaps more1998), and hence we predicted this residue could act
dramatically, the sensitivity range of the m6 transfec-through an “altered MHC” mechanism of TCR recogni-
tants that expressed CD8 was now driven to the verytion. The m6 TCR, like wt 2C TCR, recognizes the QL9-
high end of the spectrum (SD50 values from 100 pM top5 variants with a range of affinities (Holler et al., 2000;
Table 1). Thus, the QL9-p5 variants in conjunction with 1 pM).
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Figure 2. IL-2 Production by CD8-Negative,
CD8, and CD8 Transfectants Stimulated
with Ld- or Kb-Specific Peptides
(A) Transfectants that expressed the 2C wild-
type  TCR, the m6 mutant TCR, or the
m13 mutant TCR were stimulated with the
indicated concentrations of QL9 (open
squares) or p2Ca (closed circles) in the pres-
ence of T2-Ld antigen-presenting cells.
(B) Transfectants that expressed the 2C wild-
type  TCR or the m67 mutant TCR were
stimulated with the indicated concentrations
of SIYR (open squares) or dEV8 (closed cir-
cles) in the presence of T2-Kb antigen-pre-
senting cells. IL-2 was measured by ELISA
after 30 hr of culture.
Relationship of Peptide Activity and pepMHC Stability ported by the observation that the three peptides (QL9,
Y5, p2Ca) for which the 2C TCR has the highest affinitiesWhile the analysis described above examined the rela-
tionship between TCR affinity and sensitivity, it did not (close to 1 M) each showed activity closer to the m6
curve.address another important factor in the activity of a
peptide—its stability as a complex with the class I prod- The results shown in Figure 1 for the dEV8/Kb and
SIYR/Kb-reactive TCRs further support this relationshipuct. The position 5 variants of QL9 show three orders
of magnitude differences in their ability to stabilize Ld between peptide activity and pepMHC stability. The sta-
bility of SIYR for Kb is approximately 100-fold greater(as determined by upregulation assays with T2-Ld
[Schlueter et al., 1996]). The eight residue peptide p2Ca than that of dEV8 (Tallquist et al., 1998). The m67/
CD8 transfectant exhibited a 30-fold higher SD50 forhas reduced activity compared to QL9 because it is less
stable than QL9 or any of the position 5 variants of QL9. SIYR (3 nM) than for dEV8 (110 nM) and the m33/CD8
transfectant exhibited a 75,000-fold higher SD50 for SIYRThe alanine variant of p2Ca called p2Ca-A8 is further
reduced in stability with Ld because of the alanine substi- (2 nM) than for dEV8 (158,000 nM) (data not shown;
Holler et al., 2002).tution of the leucine anchor residue at position 8. To
examine the relationship between peptide activity and
pepMHC stability, SD50 values for these two peptides Relationship of Peptide Activity
and TCR:pepMHC Affinityand the panel of QL9 variants were plotted versus the
log of pepMHC stability (Figure 4). This analysis revealed To directly examine the relationship between peptide
activity and TCR:pepMHC affinity, SD50 values of pep-that there is almost a 1:1 correspondence of stability
with activity, within each of the CD8 TCR transfec- tides with known TCR:pepMHC affinities were plotted
versus KD values. The Ld and Kb systems differed intants. If we estimate the combined CD8/TCR affinity for
pepMHC is approximately fixed at 
 1 M for m6 and maximum achievable SD50 values, perhaps due to inher-
ent differences in the properties of these class I mole-1 to 50 M for 2C, then the pepMHC stability dictates
the sensitivity of the peptide. This interpretation is sup- cules (e.g., surface turnover, binding of endogenous
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Figure 3. Sensitization Doses of Various QL9
Position 5 Variant Peptides
IL-2 production by transfectants stimulated
with various peptides was measured as de-
scribed in the Experimental Procedures. The
amount of peptide that yielded 50% of the
maximum IL-2 release (SD50) was calculated
by linear regression of IL-2 curves (see Figure
S1 at http://www.immunity.com/cgi/content/
full/11/2/255/DC1). The log of the SD50 value
was plotted for each of the peptides used to
stimulate transfectants: (A) 2C and m6, CD8-
negative; (B) 2C CD8-negative, 2C/CD8,
and 2C/CD8; (C) m6 CD8-negative, m6/
CD8, and m6/CD8. In Figures 3
through 5, log SD50 values represent the mean
of at least two assays. Error bars indicating
one standard deviation are included for each
point (for some points these error bars are
not apparent as they are smaller than the size
of the symbol).
peptides) (Hansen et al., 2000). In order to include data As shown in Figure 5, there is a sharp threshold of
CD8-independent activity that occurs at approximatelyderived from both systems, the SD50 values obtained for
recognition of Ld and Kb were plotted on separate axes a KD of 1 M, or a lifetime of dissociation of 30 s. CD8-
independent T cell activity increases above this thresh-on a double y axis plot. This treatment essentially nor-
malizes the activity data relative to the maximum SD50 old and appears to plateau at the high end of the range
of affinities examined here. Thus, the optimum affinitiesvalue obtained for each MHC (QL9-M5 recognition by
CD8m6 and SIYR recognition by CD8m67, re- exceed about 50 nM and lifetimes of dissociation of
about 150 s. The dramatic role of CD8 and CD8 inspectively). KD values measured for 2C TCR:p2Ca/Ld
and the 2C TCR:QL9/Ld have varied considerably in the driving this TCR affinity threshold lower is seen with all
of the TCR:pepMHC interactions that exhibit affinitiesliterature (see Table 1). The basis for this variability is
not clear. In Figure 5 we have used the KD of 1000 nM lower than 3 M, or lifetimes of less than 10 s (Figure
5). As indicated above, the contribution of CD8 at thesefor 2C TCR:QL9/Ld as this represents approximately the
average value among various measurements. Data for lower affinities is extraordinary. In these cases, the affini-
ties of TCRs can be as low as 40 M, yet very potent Tp2Ca and p2Ca-A8 are not included in Figure 5 as these
activities are low not because of TCR affinity but due cell activity is achieved. The results with m67 and
dEV8/Kb in comparison to 2C and dEV8/Kb imply thatto reduced pepMHC stability (see Figure 4).
Immunity
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rate. Further analysis of additional TCR mutants with
defined on- and off-rates should clarify this observation.
Discussion
Many studies have been directed at elucidating the rela-
tionships between T cell activity and the properties of
TCR affinity, dissociation rate, and CD8 dependence.
Despite these efforts, questions about the overriding
principles that govern T cell activity remain. The most
significant obstacle to a thorough analysis has been the
very low affinities associated with normal TCR:pepMHC
interactions. To overcome these problems, we engi-
Figure 4. Relationship of Peptide Activity and pepMHC Stability neered TCRs with a wide range of affinities and reintro-
Log of the SD50 values were plotted versus the log of the pepMHC duced these into T cell hybridomas. Using these
stabilization values for QL9 position 5 and p2Ca variant peptides. transfectants, we observed an unambiguous, direct rela-
CD8-positive transfectants with wild-type 2C TCR (open square) tionship between affinity and peptide activity (Figure
or with mutant TCR m6 (closed circle) were assayed with the indi-
5). In contradiction to some models, there was not ancated peptides to determine SD50 values (see Figure S1 at http:).
optimal lifetime for the TCR:pepMHC interaction, eitherStability values of the pepMHC interactions were measured by an
in the presence or absence of CD8. Furthermore, CD8Ld-upregulation assay; values are taken from Schlueter et al., 1996.
The linear regressed lines were plotted for each transfectant to show played an essential role in low-affinity reactions that are
a direct correlation between peptide activity and MHC-stabilization typical of virtually all normal T cells (Figure 5).
of a peptide. Whether the biological activity of a T cell is dependent
on the equilibrium binding affinity of the TCR:pepMHC
interaction or on the dissociation rate (i.e., lifetime) of
the on-rate is as important as the off-rate in T cell activ- the interaction has been the subject of various debates.
ity. That is, the affinities of the two interactions differ by Because affinity is determined by the association and
over 10-fold, due exclusively to an increase in the on- dissociation rates, it has almost always correlated with
dissociation rate (i.e., association rates have been uni-
formly slow for normal TCR:pepMHC). With a few excep-
tions, it has been difficult to identify appropriate
TCR:pepMHC pairs with fixed dissociation rates but dif-
ferent association rates that would be capable of ad-
dressing the question (Alam et al., 1999; Baker et al.,
2000; Boniface et al., 1999; Kersh et al., 1998; Matsui
et al., 1994). In the dissociation rate model, T cells that
express TCRs with the same dissociation rates but dif-
ferent association rates would have equal T cell activity.
In the affinity model, these T cells would have different
activity. Most of the high-affinity interactions studied in
the present report have both longer lifetimes of dissocia-
tion than the wild-type TCR:pepMHC and faster associa-
tion rates. An inherent problem with lower affinity inter-
actions is that kinetic measurements are subject to
errors not encountered with higher affinity interactions
(Rudolph et al., 2002). Hence it is prudent not to overin-
terpret activity data from interactions such as m67
TCR:dEV8/Kb compared to 2C TCR:dEV8/Kb. As equilib-
rium binding data is typically more reliable than kinetic
data for the lowest affinity interactions, the KD values
were plotted versus SD50 values (Figure 5). This analysis
Figure 5. Relationship of Peptide Activity and TCR:pepMHC Affinity revealed a very clear dependence of activity on the affin-
SD50 values of various peptides were plotted versus the equilibrium ity of the TCR:pepMHC interaction.
affinity constants (KD) of the corresponding TCR:pepMHC interac- In a related view of the mechanism of T cell triggering,
tion (Table 1). In order to include values from the Ld and Kb systems,
it has been predicted that long lifetimes of dissociation,SD50 values from the two different antigen-presenting cell systems
above normal TCR:pepMHC interactions, may be detri-(T2-Ld and T2-Kb) are shown on the two Y-axes. The points represent
data derived from CD8-negative transfectants (blue circles) and mental to T cell activity because serial triggering of multi-
CD8 transfectants (red squares) of the corresponding TCR ple TCRs by a single pepMHC complex would be hin-
transfectant. The corresponding TCR/pepMHC interactions are dered (Valitutti et al., 1995; Viola et al., 1997). An earlier
shown at the bottom of the figure. The range of KD values that study supported this view of an “optimum dwell time”
correspond to affinities measured for known TCR:syngeneic MHC
using a T cell hybridoma system that expressed CD8interactions from in vivo CTLs are shown. This range falls exclusively
and TCRs against VSV/Kb (Kalergis et al., 2001). Ourin the CD8-dependent category, as determined by TCR-transfection
studies (not necessarily anti-CD8 antibody inhibition studies). findings that argued against this hypothesis involved a
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CD8-negative system, QL9/Ld, leaving open the possibil- plexes (Fahmy et al., 2001). It is not possible to determine
whether these thresholds of TCR engagement areity that CD8 was somehow involved in the reduced activ-
ity (Holler et al., 2001). We find here that this is definitely reached through continuous interactions of a TCR/CD8
complex or the sum of multiple interactions, as has beennot the case, as potent activity was observed for CD8
transfectants that expressed TCR with lifetimes that are suggested (Rosette et al., 2001).
The lack of correlation between TCR affinity and Tover 1000 s (100 times that of normal interactions). Thus,
the “serial triggering” hypothesis, at least in its present cell activation observed for some peptides is a result of
reduced stability of the pepMHC complexes over theform, does not appear to account for T cell activity. The
results support the notion that very few TCRs need to course of the activation assay. For example, m6 and
m13 TCRs bind to p2Ca/Ld with higher affinity andbe triggered to stimulate a T cell. This threshold number
of TCRs can be achieved through the TCR alone (above longer off-rates than many of the QL9 variants. Yet the
m6 and m13 transfectants showed reduced activitya KD value of 1 M) or by the combined affinities of TCR/
CD8 for the pepMHC. Whether high-affinity interactions toward p2Ca relative to the majority of other peptides.
Previous work has shown that the 2C receptor bindsmight obviate the need for classical immunological syn-
apses or supramolecular activation clusters remains to p2Ca and p2Ca-A8 with similar affinities, but the p2Ca-
A8 variant stimulated 2C transfectants at only the verybe seen (Lee et al., 2002a; Potter et al., 2001).
During the review of this manuscript, a mathematical highest concentrations (100 M) (Schlueter et al.,
1996). A similar argument can be made for the differ-model based on the earlier results of Kalergis et al.
(2001) was published (Coombs et al., 2002), as were ences in activity of dEV8/Kb and SIYR/Kb for T cells that
express the 2C TCR, compared to T cells that expresstwo reviews with similar conclusions (Lee et al., 2002b,
2002c). The argument that there is an optimal dwell time m67. SIYR has been shown to have a 100-fold greater
stabilizing effect for Kb (Tallquist et al., 1998) and thusrests largely with the results presented by Kalergis and
Coombs, compared to those presented here. Their stud- the stabilization properties of the peptide dominate its
activity. Depending on the strength of TCR/pepMHCies examined the N30.7 TCR and several N30.7 TCR
mutants that are specific for a VSV peptide bound to binding, the threshold of T cell activation by a particular
peptide is a function of the antigen density on APCsKb. The analyses revealed two TCR mutants (G99A and
G97A/G99A) that exhibited improvements of approxi- (Slansky et al., 2000). This density is not static, and the
affinity and kinetics of the peptide interaction with themately 2-fold in apparent affinity and lifetime (t1/2), com-
pared to the wt TCR. Stimulation of T cells transfected MHC dictate pepMHC density over time. Whereas pep-
tide variants with high affinity for Ld are able to achievewith these two TCR mutants by VSV/Kb was markedly
reduced compared to wt N30.7 TCR transfectants (as and maintain threshold density at low concentrations,
higher concentrations of p2Ca and p2Ca-A8 are re-judged by IL-2 release and TCR downregulation). Unfor-
tunately, the apparent affinity and t1/2 measurements for quired. Interestingly, when the affinity of the TCR is
higher (as for m6 transfectants), the correspondencethe N30.7 TCRs cannot be directly compared to those
in the present study, as they were made with tetrameric between SD50 and peptide stability is nearly one to one
(Figure 4).pepMHC reagents and therefore do not represent intrin-
sic binding constants. Furthermore, their measurements The dramatic effects of CD8 on T cell activity for lower
affinity TCR:pepMHC interactions is in part a conse-were made at 4C whereas the measurements reported
here for the 2C TCR mutants were performed at 25C. quence of binding synergism. CD8 dimers bind to
class I pepMHC complexes with low affinities (KD 200As there can be large temperature effects on TCR:pMHC
interactions (Alam et al., 1999; Schlueter et al., 1996; M), but the binding is characterized by on- and off-
rates that are much faster than TCR:pepMHC interac-Willcox et al., 1999), it remains to be seen if the same
relative binding constants are observed for the N30.7 tions (Gao et al., 2000; Wyer et al., 1999). Our results
demonstrated a synergistic affect of CD8 with CD8TCRs at higher temperatures. The basis of the tempera-
ture effect is thought to be TCR conformational mobility, in that CD8 T cells were 10- to 100-fold more active
than the CD8 transfectants alone. However, a majorso it may be particularly important to consider tempera-
ture when comparing TCRs with mutations in glycines, contribution to T cell activity was observed with CD8
transfectants alone. It is possible that stoichiometricwhich are known to have significant effects on confor-
mation. expression of CD8 and CD8 might reveal a larger
impact of CD8 on T cell activity.The optimum peptide sensitivity that was achieved
(SD501 pM) is probably limited by the threshold number The suggestion that CD8 is absolutely necessary for
the activity of normal CD8 T cells against syngeneicof TCRs required to productively signal a T cell. While
our studies do not allow us to assign an exact number, ligands is supported by what is known about the affini-
ties of TCRs, in the context of our results (Figure 5).the affinities of the pepMHC interactions studied here
suggest that fewer than 100 complexes are needed for Affinities of normal syngeneic TCR:pepMHC interac-
tions have been measured in only a few systems (Davisactivity (Schodin et al., 1996b). The ability of CD8 to
associate with p56Lck most likely further lowers the num- et al., 1998; Gascoigne et al., 2001), but it appears that
these affinities do not exceed approximately 3 M.ber of TCR complexes required for signaling (Purbhoo
et al., 2001). As an example, whereas 100 TCRs engaged Based on the relationships established in Figure 5, these
T cells will require CD8 for activity. In contrast, twoby pepMHC might be required to signal productively, it
is possible that as few as 10 TCR/CD8 complexes might allogeneic TCR:pepMHC interactions (2C TCR:p2Ca/Ld
and BM3.3 TCR:pBM1/Kb) have affinities of about 1 tobe required. We presume that engagement refers not
to a single monovalent interaction but requires some 3 M (Garcia et al., 1997; Reiser et al., 2000) and the
V14V TCR found on NKT cells has recently beendegree of crosslinking between two or more TCR com-
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of free TCR present at half-maximal binding. Flow cytometric off-shown to have an affinity of about 0.3 to 1 M for
rate assays were performed as described (Holler et al., 2001).-galactosylceramide/CD1 (Sidobre et al., 2002). 2C T
SPR measurements were performed on a BIAcore 3000 instru-cells, BM3.3 T cells (Guimezanes et al., 2001), and NKT
ment. Kinetic measurements were performed by immobilizing200
cells (Sidobre et al., 2002) do not require CD8 for activa- response units (RU) of biotinylated-pepMHC on a streptavidin sur-
tion, consistent with the results here that these affinities face (BIAcore) followed by injections of various concentrations of
purified monomeric TCR at a flow rate of 50 l/min in PBS/EDTA (3are outside the KD range found to be CD8 dependent.
mM) at 25C. Response curves were fitted to a 1:1 Langmuir bindingIt should be noted that many studies claiming CD8 inde-
model. Equilibrium measurements were performed by immobilizingpendence for T cells involved in syngeneic TCR:pepMHC
100-1000 RU of biotin-SIYR/Kb or dEV8/Kb followed by injectionsinteractions have not performed transfection studies as
of TCR at a flow rate of 5 l/min. Steady state responses were fitted
presented here but have used anti-CD8-antibody inhibi- (versus TCR concentration) to a 1:1 model (Baker and Wiley, 2001).
tion as the measure of CD8 dependence. These results For all experiments, responses from a blank surface prepared by
immobilizing the null pepMHC, OVA/Kb, were subtracted from bind-are difficult to interpret as it is not possible to block all
ing data.CD8 molecules with the antibody approach (Schodin et
Equilibrium binding of soluble monomeric TCRs to SIYR/Kb oral., 1996b).
dEV8/Kb was monitored in a competition ELISA. Anti-IgG2a antibodyFinally, the results presented here raise the question
was immobilized at 10 g per ml to wells of a 96-well plate, followed
as to why physiological TCR affinities have evolved to by addition of antibody B8.24.3 (IgG2a) that binds to 12 of Kb.
be in the low range that requires CD8 in normal synge- Biotin-labeled SIYR/Kb or dEV8/Kb was added at half-maximum con-
centrations in the presence or absence of various concentrationsneic MHC reactions. We have recently presented evi-
of soluble TCR. KD values were determined using the Cheng-Prusoffdence that higher affinity TCRs against a foreign
equation: KD  (TCR)50%/(1  (B8.24.3)/KD(Ab:pepMHC)), where (TCR)50%pepMHC exhibit an increased probability that they will
is the concentration of TCR that yielded 50% inhibition of bindinghave higher affinity for the self-peptide-MHC complex
(Cheng and Prusoff, 1973). KD values shown assumed that concen-that is involved in positive selection (Holler et al., 2002). tration of bound anti-Kb antibody was below KD of the Ab:pepMHC
Hence, T cells that bear these TCRs would be negatively interaction (10 nM). The KD values calculated using this assumption
agreed well with affinities that could be measured by other methods.selected and not exported to the periphery. It has been
proposed that the immune system generates a reper-
T Cell Transfectionstoire of flexible TCRs that can crossreact with diverse
Full-length 2C, m6, m13, m33, m67, and 2C cDNAs wereforeign antigens (Kersh and Allen, 1996; Mason, 1998).
cloned into a modified form of the SFFV expression plasmid and
The system has sacrificed high-affinity TCRs that could transfected into the T cell hybridoma line 58/ as previously de-
potentially mediate greater T cell activity in order to scribed (Holler et al., 2001). CD8 and CD8 genes were kindly
maintain T cells that can respond to diverse pathogens provided by Dr. Jane Parnes and cotransfected into TCR 
transfectants using a hygromycin selectable vector. Initial screening(or tumor antigens). To enhance the potency of the sys-
of colonies with F23.1 and F23.2 was performed in order to isolatetem, the CD8 coreceptor system can dramatically am-
transfectants that had approximately the same level of  chain.plify the effects of the lower affinity TCRs.
Screening for CD8 and CD8 levels was done with antibodies 53-
6.7 and 53-5.8, respectively. For T cell activity measurements, TCR
Experimental Procedures
transfectants (7.5  104 ) were incubated with T2-Ld or T2-Kb cells
(7.5  104 ) and various concentrations of peptides in 96-well
Peptides
U-bottom plates at 37C and 5% CO2. After 30 hr, supernatants wereSIYR (SIYRYYGL), dEV8 (EQYKFYSV), p2Ca (LSPFPFDL), QL9
harvested and assayed for IL-2 by ELISA.
(QLSPFPFDL), and QL9 variant peptides were synthesized by stan-
dard F-moc chemistry at the Protein Sciences Facility at the Univer-
Acknowledgments
sity of Illinois, Urbana, IL, and were purified by C-18 reverse-phase
HPLC using a linear acetonitrile gradient. Peptide purity and concen-
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Soluble TCR Production
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of CuSO4 to a final concentration of 500 M. Supernatants were
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